We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:AVTX
​
​
logo

Avalo Therapeutics (AVTX)

Nasdaq • AVTX • US05338F3064

7.07Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 21, 2026, ORTEX estimated 28.2% of free float sold short, 9.1 days to cover, cost to borrow 0.54%. Sign up for live short interest data.

Market Cap

379m USD | # 6440 in US

Volume

1.55m shares | 23.78m USD

Shares Outstanding

53.63m

Free Float Shares

69.56% | 37.31m

DB:C6K0

News

AVTX key data

Avalo Therapeutics (Nasdaq: AVTX) has a market capitalization of $379.16M. Last close $7.07 (as of 2026-11-05); 52-week range $6.53 to $24.27. ORTEX data as of 2026-10-21: short interest was 28.16% of free float, 9.1 days to cover and the average cost to borrow was 0.54%. Sign up for live short interest data.

  • AVTX news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.